SissonJC, FreitasJ, McDougallIR, DauerLT, HurleyJR, BrierleyJD, EdinboroCH, RosenthalD, ThomasMJ, WexlerJA, AsamoahE, AvramAM, MilasM, GreenleeC. The American Thyroid Association Taskforce on Radiation Safety 2011 Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid, 21:335–346.
2.
United States Nuclear Regulatory Commission NRC: 10 CFR 35.75 2007 Release of individuals containing unsealed byproduct material or implants containing byproduct material. www.nrc.gov/reading-rm/doc-collections/cfr/part035/part035-0075.html. 2011 June 21.
3.
United States Nuclear Regulatory Commission 2008 NRC Regulatory Issue Summary 2008-11. Precautions to protect children who may come in contact with patients released after therapeutic administration of iodine-131. http://pbadupws.nrc.gov/docs/ML0803/ML080380666.pdf. 2011 June 21.
4.
BarringtonSF, O'DohertyMJ, KettleAG, ThomsonWH, MountfordPJ, BurrellDN, FarrellRJ, BatchelorS, SeedP, HardingLK. 1999. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur J Nucl Med, 26:686–692.
5.
MatheoudR, ReschiniE, CanziC, VoltiniF, GerundiniP. 2004. Potential third-party radiation exposure from outpatients treated with 131I for hyperthyroidism. Med Phys, 31:3194–3200.
6.
MathieuI, CaussinJ, SmeestersP, WambersieA, BeckersC. 1999. Recommended restrictions after 131I therapy: measured doses in family members. Health Phys, 76:129–136.
7.
National Council on Radiation Protection and Measurements, National Council on Radiation Protection and Measurements, Scientific Committee 91-1 on Precautions in the Management of Patients Who Have Received Therapeutic Amounts of Radioactivity 2007 Management of Radionuclide Therapy Patients. National Council on Radiation Protection and Measurements: Bethesda, MD.
8.
StabinMG, WatsonEE, MarcusCS, SalkRD. 1991. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism. J Nucl Med, 32:808–813.
9.
HoweDB, BeardsleyM, BakshSR. 2008. NRC: Consolidated Guidance About Materials Licenses: Program—Specific Guidance About Medical Use Licenses (NUREG-1556, Volume 9, Revision 2) Appendix U: Model procedure for release of patients or human subjects administered radioactive materials. www.nrc.gov/reading-rm/doc-collections/nuregs/staff/sr1556/v9/r2/sr1556v9r2-final.pdf#app-u. 2011 June 21.
10.
HustonAC, AronsonSR. 2005. Mothers' time with infant and time in employment as predictors of mother-child relationships and children's early development. Child Dev, 76:467–482.
